Profile and Characteristics of Analgesic Use in Myalgia Cases at Soromandi Health Center

Authors

  • Rahmatillah Rahmatillah Puskesmas Soromandi Kabupaten Bima Nusa Tenggara Barat, Indonesia

DOI:

https://doi.org/10.33394/hjkk.v12i6.13866

Keywords:

profile, characteristics, analgesic use, Myalga, Soromandi

Abstract

Myalgia is a common muscle pain condition that often requires pharmacological analgesic therapy for pain management. This study aims to determine the profile and characteristics of analgesic use in myalgia patients at Puskesmas Soromandi. Data were obtained through a retrospective study of patient medical records from January to December 2023, using consecutive sampling method. The data were analyzed descriptively and presented in tables and percentages. The results show that the most common demographic groups using analgesics for myalgia were patients aged 46-65 years (46.53%), female (57.4%), and farmers (48.5%). The most frequently used analgesic was ibuprofen 400 mg (40.59%), which was more often combined with supplements rather than used as monotherapy. The most common duration for analgesic administration was 5 days (56.43%). Conclusion: Myalgia patients are generally aged 46-65 years, with a predominance of females and farmers. Ibuprofen and a 5-day duration of analgesic treatment are the most frequently applied approaches in myalgia cases at Puskesmas Soromandi.

References

Dinas Kesehatan Provinsi Nusa Tenggara Barat. (2024). Profil Kesehatan Nusa Tenggara Barat Tahun 2023. Dinas Kesehatan Provinsi Nusa Tenggara Barat. Diakses dari https://dinkes.ntbprov.go.id

Te Riele MG, Schreuder TH, van Alfen N, Bergman M, Pillen S, Smits BW, van der Wilt GJ, Groenewoud H, Voermans NC, van Engelen BG. The yield of diagnostic work-up of patients presenting with myalgia, exercise intolerance, or fatigue: A prospective observational study. Neuromuscul Disord. 2017 Mar;27(3):243-250.

Pramesi AY, Sutanto FR. Hubungan motivasi, kepercayaan dan sikap terhadap perilaku klien melakukan akupunktur pada kasus myalgia di Griya Sehat "X". Dohara Publisher Open Access Journal (DPOAJ). 2023;2(11):910-7

Sumardiyono S., Lowa NW., Azzam AM., Huda KN., Nurfauziah N. Kejadian Myalgia Pada Lansia Pasien Rawat Jalan. JRST J Ris SAINS DAN Teknol. Published Online 2017. Doi:10.30595/Jrst.V1i2.1442.

Okuyan DY, Gölen MK. Relationship between myalgia and laboratory parameters in hospitalized patients with COVID-19. J Contemp Med. 2022;12(2):306-11

Cheema, R., Chang-Miller, A., & Aslam, F. (2019). Myalgia with Elevated Inflammatory Markers in an Obese Young Female: Fibromyalgia or Polymyalgia Rheumatica?. The American journal of case reports, 20, 659–663.

Gupta, V., Ezhilarasan Santhi, S., Ravi, S., & Ramanan, E. (2022). Rheumatological and Musculoskeletal Complications in Diabetes Patients. Journal Of Endocrinology And Metabolism, 12(4-5), 117-124.

Queme, L. F., & Jankowski, M. P. (2019). Sex differences and mechanisms of muscle pain. Current opinion in physiology, 11, 1–6..

Azis, P., Juhanto, A., & Rahmawati. (2022). Hubungan postur kerja dengan kejadian myalgia pada petani di Kecamatan Bungaya Kabupaten Gowa. UNM Environmental Journals, 5(2), 1–6

Parri N, Lazzeri S. (2020). Efficacy of ibuprofen in musculoskeletal post-traumatic pain in children: A systematic review. PLoS ONE 15(12): 1-11

Isnenia, Penggunaan non-steroid antiinflamatory drug dan potensi interaksi obatnya pada pasien muskuloskeletal, Pharm J Indones, 2020;6(1):47–55

Calderon-Ospina, C. A., Nava-Mesa, M. O., & Arbeláez Ariza, C. E. (2020). Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysis. Pain medicine (Malden, Mass.), 21(4), 766–781

Nava-Mesa, M. O., & Aispuru Lanche, G. R. (2021). Papel de las vitaminas B, tiamina, piridoxina y cianocobalamina en el dolor de espalda y otras condiciones musculoesqueléticas: revisión narrativa [Role of B vitamins, thiamine, pyridoxine, and cyanocobalamin in back pain and other musculoskeletal conditions: a narrative review]. Semergen, 47(8), 551–562.Monthly Index of Medical Speci

Tai, F. W. D., & McAlindon, M. E. (2021). Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clinical medicine (London, England), 21(2), 131–134.

Schaffer, D., Florin, T., Eagle, C., Marschner, I., Singh, G., Grobler, M., Fenn, C., Schou, M., & Currow, K. M. (2006). Risk of serious NSAID-related gastrointestinal events during long-term exposure: A systematic review. The Medical Journal of Australia, 185(9), 501–506

Downloads

Additional Files

Published

2024-12-31

How to Cite

Rahmatillah, R. (2024). Profile and Characteristics of Analgesic Use in Myalgia Cases at Soromandi Health Center. Hydrogen: Jurnal Kependidikan Kimia, 12(6), 1520–1528. https://doi.org/10.33394/hjkk.v12i6.13866

Issue

Vol. 12 No. 6 (2024): December 2024

Section

Articles

Citation Check

License

License and Publishing Agreement
In submitting the manuscript to the journal, the authors certify that:

  1. They are authorized by their co-authors to enter into these arrangements.
  2. The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
  3. That it is not under consideration for publication elsewhere,
  4. That its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
  5. They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
  6. They agree to the following license and publishing agreement.

Copyright
Authors who publish with Hydrogen: Jurnal Kependidikan Kimia agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Licensing for Data Publication

Hydrogen: Jurnal Kependidikan Kimia uses a variety of waivers and licenses, that are specifically designed for and appropriate for the treatment of data: Open Data Commons Attribution License, http://www.opendatacommons.org/licenses/by/1.0/ (default) Other data publishing licenses may be allowed as exceptions (subject to approval by the editor on a case-by-case basis) and should be justified with a written statement from the author, which will be published with the article.